GPT and neoplasm: These results together demonstrated that regardless of the differentiation status, 131I‐ALT‐836 could specifically target THJ‐16T tumors and 131I‐ALT‐836 RIT could induce tumor regression and prolong the survival of the tumor‐bearing mice.